Journal of Clinical Microbiology · 2019 · 41 citations · 12 references
Life SciencesInfectious DiseasesMolecular BiologyHepatologyMolecular VirologyVirologyAntiviral TherapyLiver DiseaseLiver Function TestsNucleos(t)ide Analog TherapyViral DiagnosticsViral HepatitisChronic Viral HepatitisHepatitis B Virus ReplicationHepatitis Virus Diagnosis
< 0.001). In addition, we focused on the 108 HBV-infected patients with HBV DNA levels of <500 IU/ml; it was surprising to find that in 17.57% (13/74) of cases, HBV pgRNA could be detected even when the HBV DNA level was below 20 IU/ml. In conclusion, HBV pgRNA levels in serum can be a surrogate marker for intrahepatic HBV cccDNA compared with serum HBV DNA and HBsAg. The detection of serum HBV pgRNA levels may provide a reference for clinical monitoring of cccDNA levels and the selection of appropriate timing for discontinuing antiviral therapy, especially when HBV DNA levels are below the detection limit.
12